ARCHIVES

In Senate testimony, NCI director uses survival rate as measure of progress for goal to “eliminate suffering and death due to cancer.”

This article is from The Cancer Letter archive.

Vol. 31 No. 30 | July 29, 2005

Download PDF Visit The Full Archive

Related Articles

Cancer Meetings Listed For Next Three Months

September 20, 1996

In Brief: Tomasi To Resign As Roswell Park President; Committee To Study NIH Grant Review Issues

December 15, 1995

Pathology Review Confirms Reserpine As Carcinogen

March 14, 1980

Oncologists Don’t Demand Increased Survival When Ordering Expensive Drugs, Survey Finds

April 13, 2012

Book By Clinical Researcher Makes Case For Nationwide Reforms

July 30, 1993

NCI Advisory Group, Other Cancer Meetings For April, May

March 26, 1976